Loading...
•
Dec 31, 2023
Alphatec Q4 2023 Earnings Report
ATEC reported Q4 and full-year 2023 financial results.
Key Takeaways
Alphatec Holdings, Inc. reported Q4 2023 total revenue of $138 million. Full year 2023 total revenue grew 37% to $482 million. The company expects full year 2024 total revenue to approximate $595 million.
Portfolio-wide strength drove fourth quarter 2023 surgical revenue growth of 34% with an acceleration in volume growth to 29% compared to 24% in the prior quarter.
Expanded lateral platform with full launch of Lateral TransPsoas (LTP™) + Midline ALIF approaches and Calibrate LTX™, a lateral expandable implant.
Elevated the procedural sophistication of comprehensive portfolio with launch of 15 new products and line extensions in 2023.
Trained over 500 surgeons in 2023, contributing to a 27% increase in surgeon users compared to 2022.
Forward Guidance
The Company continues to expect total revenue for the fiscal year ended December 31, 2024, to approximate $595 million, reflecting growth of approximately 23% compared to 2023. This includes surgical revenue of $530 million and approximately $65 million of EOS revenue. The Company expects full year 2024 non-GAAP adjusted EBITDA to approximate $22 million, which implies 560 basis points of improvement in adjusted EBITDA margin compared to full year 2023.
Positive Outlook
- Total revenue for fiscal year 2024 expected to approximate $595 million.
- Revenue growth of approximately 23% compared to 2023.
- Surgical revenue of $530 million.
- EOS revenue of approximately $65 million.
- Full year 2024 non-GAAP adjusted EBITDA to approximate $22 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...